Publication | Closed Access
Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.
23
Citations
0
References
1985
Year
Immunocompetent CellsNeoadjuvant TherapySquamous Cell CarcinomaT-regulatory CellImmunologyPathologyImmunotherapyInflammationTotal T CellsNasopharyngeal CancerTumor ImmunityNeck OncologyHead And Neck OncologyRadiation OncologyCancer ResearchT Cell SubsetsAllergyAutoimmune DiseaseMedicineCancer DiagnosisImmune SurveillanceAutoimmunityT Cell ImmunityCancer ImmunosurveillanceNeck PathologyHead And Neck CancerHead And Neck Squamous Cell CarcinomaOncology
Patients with squamous cell carcinoma of the head and neck have impaired T cell function and poor tumor-specific responsiveness. Disproportionate levels of circulating immunocompetent cells could be one reason for this diminished immunity. In this study, a panel of monoclonal antibodies and flow cytofluorometry were used to define the relative proportions of selected immune cell populations. We detected a deficiency of the interleukin-2-producing subset of T helper-inducer cells (TH 5.2+) in these patients. Our data showed no significant differences in circulating levels of total T cells, T cell subsets, B cells, monocytes, or natural killer cells when compared to age, alcohol- and tobacco-use matched controls.